Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women

This study has been completed.
Bristol-Myers Squibb
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: November 2, 1999
Last updated: March 28, 2012
Last verified: August 2004
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2001
  Estimated Primary Completion Date: No date given